
Richard Foster, former senior partner of McKinsey, mentioned in the book "The Attacker's Advantage": "There have always been attackers and defenders in the business world. Only through continuous attacks, knowing how to use new methods to push the limits, can there be new changes. The key for attackers may lie in technological advantages and constantly expanding their thinking."Technical advantages often serve as the confidence of the attacker, and in the field of picosecond laser beauty, a company's technical superiority focuses on who possesses more precise energy, more stable quality, and better clinical benefits.Recently, the National Medical Products Administration approved the Nd:YAG frequency-doubled picosecond laser therapy device from Nanjing Vishee Medical Technology Co., Ltd. PicoV has landed powerfully, becoming the first picosecond product in China for treating pigmented diseases that has been verified by large-scale registration clinical trials in top-tier hospitals.
▲PicoV Product Image
It is reported that,The PicoV clinical trial was led by top hospitals in the dermatology field in China, namely the Dermatology Hospital of the Chinese Academy of Medical Sciences and the Plastic Surgery Hospital of the Chinese Academy of Medical Sciences. It was compared with imported international top-tier picosecond devices, and both achieved a 100% effective rate in clearing pigmentation disorders.The experimental process was also an ultimate comparison, using a double-blind experiment where two types of picosecond devices were applied to the left and right cheeks of the subjects. The final result confirmation was made only after precise counting by three doctors for each subject before and after the treatment.

Picosecond (ps) is equivalent to one hundred billionth of a second, with a speed 1000 times faster than nanosecond lasers (1ns = 1000ps). The common pulse width of picosecond lasers ranges between 400-700ps, while the pulse width of ultra-picosecond lasers further breaks through to 300-450ps, enabling more precise and effective treatment of pigmented skin conditions.For a long time, the domestic picosecond laser market has been monopolized by foreign brands. Products such as PicoWay from Syneron Medical Ltd. in the United States, PicoSure from Cynosure Inc. in the United States, and PicoCare from WonTech in South Korea are the mainstream products in the market. Their pulse widths are 300-450ps, 500ps-900ps, and ≤450ps, respectively.

Facing foreign monopolies, VISHEE has chosen to rely on its own R&D advantages to continuously develop its product offensive. By converting this R&D advantage into a technological edge, the company keeps innovating and leading industry transformations.With an ultra-short pulse width and powerful power output, the PicoV picosecond laser device effectively reduces heat accumulation during treatment, minimizes damage to surrounding skin, significantly decreases post-treatment redness and discomfort, shortens patient recovery time, and allows for a quicker return to daily life.PicoV is not only suitable for solving pigmentation problems but also can address various photoaging skin issues such as fine lines, enlarged pores, acne scars, and wrinkles through different modes and zoom functions.Its stable energy output capability effectively reduces the risk of skin overheating or damage caused by energy fluctuations, making the treatment safer, with a lower incidence of side effects and a shorter recovery period.This time, VISHEE's independently developed PicoV picosecond laser treatment instrument achieves an ultra-short pulse width superior to mainstream imported brands, effectively reducing skin thermal damage and minimizing the risk of post-inflammatory hyperpigmentation, successfully overtaking competitors and taking the lead as a latecomer.Breaking into the forefront of the industry, highlighting the rise of Chinese manufacturing.VISHEE has long been dedicated to the deep cultivation of medical device technology. It is a national-level specialized, refined, and innovative "little giant" enterprise, a national high-tech enterprise, and a STAR Market listed company. R&D capability has always been VISHEE's strongest backing.VISHEE's R&D investment last year reached 78.43 million yuan, increasing by 27.86% year-on-year, with 187 R&D personnel, accounting for 26.71% of the total number.In a single annual reporting period, VISHEE obtained authorization for 47 new patents, including 12 invention patents, 23 utility model patents, and 12 design patents, with a total cumulative number of authorized patents reaching 241.Relying on this strong R&D capability,VISHEE has gradually established technology platforms such as magnetic stimulation, electrical stimulation, electrophysiology, rehabilitation robotics, radiofrequency, and laser during its development process., continuously providing high-quality products and solutions for rehabilitation medicine,Including categories such as pelvic floor and postpartum rehabilitation, mental health rehabilitation, neurological rehabilitation, and pediatric rehabilitation.VISHEE Aesthetics, as an important brand in the medical aesthetics field of Nanjing Vishee Medical Technology Co., Ltd., adheres to the brand concept of "Achieving Free Aestheticism" and is committed to continuous exploration and innovation in the medical aesthetics field.
▲VISHEE Aesthetics Light Private Family MembersVISHEE has consistently achieved outstanding results in the fields of intimate care and body shaping, earning unanimous recognition from both B-end practitioners and C-end consumers. With the launch of its picosecond product PicoV in the field of skin aesthetics, which ranks among the top in the industry, VISHEE once again demonstrates its aggressive approach and strong R&D capabilities in the medical aesthetics sector.The acquisition of the PicoV III Class "Medical Device Registration Certificate" further expands VISHEE's aesthetic laser product portfolio and enhances the company's comprehensive competitiveness in the medical aesthetics energy-based device market.In the future, VISHEE will also build a multi-field product matrix, a multi-dimensional aesthetic layout, and a multi-domain business ecosystem, showcasing the strong foundation of Chinese manufacturing.